The Next Standard in Nutra‑Pharmaceutical Therapies
Explore Our ScienceWelcome to Exerkine
Founded on Decades of Discovery
- 18Patents
- 8Completed Human Studies
- 11Products Commercially Available
Every feature of aging - fatigue, inflammation, cognitive decline - is the result of mitochondrial dysfunction. At Exerkine, our mission is to restore and protect the body’s power source through scientifically engineered nutra‑pharmaceutical solutions. By targeting energy production at its core, we unlock stronger muscles, sharper cognition, and a healthier, longer life.
Our Science
Research & Technology
A Research Engine Focused on Cellular Energy
Exerkine’s research engine applies leading expertise in mitochondrial science, exercise physiology, and cellular metabolism to identify compounds that activate the body’s own adaptive pathways. By restoring energy production and cellular performance at the mitochondrial level, our therapies aim to correct the underlying dysfunction driving a wide range of disorders.
Two Domains, One Biological Root
Our programs span both rare genetic disorders and common acquired conditions. Genetic diseases frequently involve mitochondrial or metabolic impairments that are poorly addressed by conventional single-target drugs. Our multi-pathway approach leverages the body’s native biology to deliver broad therapeutic effects while reducing off-target risks. In acquired disorders – those that emerge and accelerate with age – mitochondrial decline drives loss of metabolic efficiency, chronic inflammation, impaired tissue repair, and reduced physiological resilience.
Advancing Therapies with Real-World Impact
Across both domains, our R&D pipeline is advancing therapies with the potential to improve strength, cognition, immune function, fertility, metabolic health, and aging-related outcomes. Early studies show meaningful improvements in muscle function, inflammation markers, fat metabolism, and other clinically relevant endpoints. The aim is direct and measurable: restore mitochondrial function so people can live healthier, longer lives.
About Us
Decades of Research, One Vision
- 570+Peer-Reviewed Publications
- h‑149Citation Index
- Featured InTIME, CBC and the Globe and Mail
Dr. Mark Tarnopolsky founded Exerkine to translate decades of human and mechanistic research into a new class of mitochondrial-targeted therapies. Every product we build is rooted in science that has already changed lives.
Meet the Team
& Chief Scientific Officer MD, PhD, FRCP(C)
Our Brand
StayAbove Nutrition
Our flagship consumer brand brings the science of Exerkine to everyday performance. StayAbove Nutrition products are formulated from our core research - built for people who refuse to settle.
Visit StayAboveNutrition.ca
Services
What We Offer
-
01
Nutra-Pharmaceutical Development
Scientifically engineered formulations targeting foundational drivers of health, grounded in mitochondrial research.
-
02
Scientific & Clinical Research
From concept development through QA to commercialization, supporting informed decisions at every stage.
-
03
Regulatory Guidance & Support
Expert Health Canada and FDA navigation ensuring a compliant, defensible path to market.
-
04
Private Label Services
Scientifically developed formulations and trusted manufacturing capabilities aligned with rigorous quality standards.
-
05
Marketing & Creative
Data-informed positioning and strategic creative that communicates effectively with scientific and consumer audiences.
-
06
Product Strategy
End-to-end guidance on product development, market positioning, and launch planning from formulation to shelf.